This doesn't tell us anything we don't already know but for the sake of completeness here is an extract from the CHMP minutes for the March meeting:
(EMEA/H/D/002831), (insulin-like growth factor 1 segment), , (hard-to-heal wounds, primarily venous leg ulcers) List of Outstanding Issues adopted on 25.09.2014. List of Questions adopted on 23.01.2014.
See also section 1.1. Pre-authorisation procedure oral explanations
An Oral explanation was held on Wednesday 25 March 2015 at 11.00.
It was agreed that the company will be provided scientific advice.
The Committee adopted the BWP Report.
The Committee noted that the applicant has withdrawn the application.
Rev
TIS Price at posting:
10.5¢ Sentiment: Hold Disclosure: Not Held
